ECHOCARDIOGRAPHY-BASED CONVOLUTIONAL NEURAL NETWORK MODEL SUPERSEDES THE CARDIOTOXICITY RISK SCORE IN PREDICTING CHEMOTHERAPY-INDUCED CARDIOMYOPATHY